Qingbo Liu
Key Laboratory Of Computational Chemistry Based Natural Antitumor Drug Research & Development, Key Laboratory Of Natural Bioactive Compounds Discovery & Modification
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Targeting Cys328 in the STAT3 DNA-binding domain with the germacrane-type sesquiterpene lactone SCP-7 inhibits colorectal Cancer growth in vitro and in vivo.
Journal: Bioorganic chemistry
Published: June 03, 2026
Structure-based discovery of a novel small-molecule inhibitor of ATG4B that modulates autophagy in esophageal squamous cell carcinoma therapy.
Journal: Bioorganic chemistry
Published: May 21, 2026
Multi-dimensional insights into Brucea javanica (L.) Merr. in cancer treatment: current status, challenges and future directions.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 08, 2026
Design, synthesis, and biological evaluation of novel ICA-II derivatives as anti-hepatocellular carcinoma agents targeting EGFR.
Journal: European journal of medicinal chemistry
Published: March 11, 2026
Performance enhancement and environmental assessment of ultra-fine tailings mortars using waste-derived binders activated by alkali-sulfate.
Journal: Environmental research
Published: February 25, 2026
Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer.
Journal: European journal of medicinal chemistry
Published: November 01, 2025
Eupalinolide B alleviates ulcerative colitis by targeting HMGB1 through modulation of the HMGB1/TLR4/MyD88/NF-κB signaling pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 13, 2025
Ga-Assisted Free-Standing Growth of CsPbBr3 Nanowires for High-Performance Optoelectronic Applications.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 26, 2025
Identification of HMGB1 as a target of 3-O-benzoyl-20-deoxyingenol in NSCLC therapy using integrated ABPP and SIP.
Journal: Acta pharmaceutica Sinica. B
Published: August 11, 2025
Unravelling the oncogenic role of eukaryotic elongation factor 2 kinase: A revisited review from underlying mechanisms to targeted therapy.
Journal: International journal of biological macromolecules
Published: July 14, 2025
Glaucocalyxin A induces autophagy-mediated ferroptosis by targeting PRDX1 and TXNRD1 proteins in non-small cell lung cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 27, 2025
Last Updated: 09/26/2026